Yahoo Finance • yesterday
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ARK Genomic Revolution ETF (Symbol: ARKG) where we have detected an approximate $73.5 million dollar outflow... Full story
Yahoo Finance • 8 days ago
In trading on Tuesday, the ARK Fintech Innovation ETF is outperforming other ETFs, up about 1.2% on the day. Components of that ETF showing particular strength include shares of Circle Internet Group, up about 8.6% and shares of Robinhood... Full story
Yahoo Finance • 8 days ago
BofA raised the firm’s price target on Guardant Health (GH) to $120 from $100 and keeps a Buy rating on the shares. The firm is updating it price targets for Life Sciences & Diagnostic Tools stocks under its coverage, the analyst tells inv... Full story
Yahoo Finance • 16 days ago
[Digital Intelligence - AI Icon Illuminated Against Financial Data and Binary Streams] J Studios Wall Street research looks to be shifting from endorsing the classic AI trade to AI adopters. Instead of the chipmakers and hyperscalers in... Full story
Yahoo Finance • last month
[Lilly Biotechnology Center in San Diego, California, USA.] JHVEPhoto Eli Lilly (LLY [https://seekingalpha.com/symbol/LLY]) officially joined the elite group of U.S. companies valued at more than $1T on Friday, becoming the tenth American... Full story
Yahoo Finance • last month
34-member consortium creates an interoperable data standard for AI and distributed analytics Notable founding members include Guardant Health, NetApp, Seagate, IBM, DDN, and Genentech PALO ALTO, Calif., November 12, 2025--(BUSINESS WIRE)-... Full story
Yahoo Finance • 2 months ago
Key Points Guardant's oncology and screening businesses are expanding at a rapid pace. New partnerships should drive further gains.10 stocks we like better than Guardant Health › Shares of Guardant Health (NASDAQ: GH) rocketed 28% higher... Full story
Yahoo Finance • 2 months ago
Guardant Health (GH) shares soared 26% amid heavy trading after the company reported overnight impro PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story
Yahoo Finance • 2 months ago
* Guardant Health press release [https://seekingalpha.com/pr/20285132-guardant-health-reports-third-quarter-2025-financial-results-and-increases-2025-revenue] (GH [https://seekingalpha.com/symbol/GH]): Q3 Non-GAAP EPS of -$0.39 beats by... Full story
Yahoo Finance • 2 months ago
Guardant Health received FDA approval for its Guardant360 CDx blood test as a companion diagnostic for Eli Lilly’s Inluriyo, targeting advanced breast cancer patients with ESR1 mutations. This regulatory milestone positions Guardant Health... Full story
Yahoo Finance • 2 months ago
S&P 500 giant Walmart and a profitable biotech are actionable, leading five stocks to watch amid a tricky market environment. Continue Reading View Comments... Full story
Yahoo Finance • 3 months ago
Technology, Medical Device, and Consumer Goods Companies Achieve Business Efficiencies with Propel One Agentic AI Solution REDWOOD CITY, Calif., October 09, 2025--(BUSINESS WIRE)--Propel, creator of the first product value management (PVM... Full story
Yahoo Finance • 3 months ago
Company Logo The GCC Liquid Biopsy Market is projected to grow from US$ 98.24 million in 2024 to US$ 309.53 million by 2033, at a CAGR of 13.60%. This rapid growth is driven by rising cancer incidence, advances in genomics technology, inc... Full story
Yahoo Finance • 3 months ago
We recently compiled a list of the 12 Best Performing Healthcare Stocks to Buy Right Now. Guardant Health, Inc. is one of them. Guardant Health, Inc. (NASDAQ:GH), a leading precision oncology company, specializes in blood-based cancer dia... Full story
Yahoo Finance • 3 months ago
What Happened? Shares of diagnostics company Guardant Health (NASDAQ:GH) jumped 1.6% in the morning session after the U.S. Food and Drug Administration (FDA) approved its Guardant360® CDx blood test as a companion diagnostic for Eli Lilly... Full story
Yahoo Finance • 3 months ago
[Cancer cells vis] koto_feja Guardant Health (NASDAQ:GH [https://seekingalpha.com/symbol/GH]) has received approval from the U.S. FDA for its Guardant360 CDx, which serves as a companion diagnostic tool. The Guardant360 CDx is specifical... Full story
Yahoo Finance • 3 months ago
This marks the second FDA-approved indication for Guardant360 CDx as a companion diagnostic in breast cancer treatment ESR1 mutations are present in 40% of HR+, HER2- advanced breast cancers PALO ALTO, Calif., September 29, 2025--(BUSINES... Full story
Yahoo Finance • 3 months ago
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: TD Cowen upgraded Paycom (PAYC) to Buy... Full story
Yahoo Finance • 3 months ago
[World Trade Center and Oculus in Lower Manhattan, NYC] AndresGarciaM/iStock Editorial via Getty Images Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the e... Full story
Yahoo Finance • 4 months ago
Strategic partnership will expand Shield to PathGroup’s 15,000+ primary care and OBGYN physicians PathGroup’s extensive network of phlebotomists and Patient Service Centers enables easier access to Shield, the more pleasant and convenient... Full story